Skip to main content

Table 1 Characteristics of patients with fever for each period

From: Changes in the proportion and severity of patients with fever or common cold symptoms utilizing an after-hours house call medical service during the COVID-19 pandemic in Tokyo, Japan: a retrospective cohort study

Characteristic

Control period (n = 5335)

Exposure period (n = 7423)

P-value

Age, years

 Median (IQR)

8 (3–11)

10 (4–33)

< 0.001

 Category, n (%)

  

< 0.001

  0–14

3147 (59.0)

4152 (55.9)

 

  15–64

2112 (39.6)

3089 (41.6)

 

   ≥ 65

76 (1.4)

182 (2.5)

 

Male sex, n (%)

2765 (48.2)

3839 (48.3)

0.90

Month, n (%)

  

< 0.001

 December

523 (9.8)

1683 (22.7)

 

 January

1704 (31.9)

2052 (27.6)

 

 February

1243 (23.3)

2062 (27.8)

 

 March

900 (16.9)

1057 (14.2)

 

 April

968 (18.1)

570 (7.7)

 

Diagnosis, n (%)

 Upper respiratory tract infection

4555 (85.4)

5875 (79.1)

< 0.001

 Influenza

1916 (35.9)

2119 (28.5)

< 0.001

 Streptococcal infection

78 (1.5)

161 (2.2)

< 0.001

 Tonsillitis

191 (3.6)

254 (3.4)

0.63

 Sinusitis

15 (0.3)

34 (0.5)

0.11

 COVID-19

0 (0.0)

6 (0.1)

0.038

 Pneumonia

38 (0.7)

61 (0.8)

0.49

 Asthma

48 (0.9)

40 (0.5)

0.021

 Otitis media

72 (1.4)

106 (1.4)

0.71

 Urinary tract infection

24 (0.4)

67 (0.9)

< 0.001

 Gastroenteritis

773 (14.5)

1064 (14.3)

0.22

 Other abdominal disease

35 (0.7)

82 (1.1)

< 0.001

 Other

138 (2.6)

427 (5.7)

< 0.001

Comorbidities, n (%)

 Hypertension

28 (0.5)

65 (0.9)

0.019

 Diabetes mellitus

21 (0.4)

40 (0.5)

0.24

 Hyperlipidemia

10 (0.2)

17 (0.2)

0.61

 Gout

3 (0.1)

5 (0.1)

0.80

 Chronic lung disease

178 (3.3)

230 (3.1)

0.45

 Heart failure

0 (0)

5 (0.1)

0.06

 Liver disease

6 (0.1)

14 (0.2)

0.27

 Cerebral infarction

8 (0.2)

14 (0.2)

0.60

 Cancer

30 (0.6)

59 (0.8)

0.12

 Collagen disease

5 (0.1)

6 (0.1)

0.27

 Dementia

3 (0.1)

7 (0.1)

0.45

  1. COVID-19 coronavirus disease; IQR interquartile range